Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of cancer
3.2.1.2 Ongoing research and development using methotrexate drugs
3.2.1.3 Rising technological advancements and demand for personalized medicine
3.2.2 Industry pitfalls & challenges
3.2.2.1 Adverse effects and safety concerns
3.2.2.2 Limited reimbursement and coverage policies
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Clinical trials on methotrexate
3.7 Pricing analysis, 2023
3.7.1 By region
3.7.2 By key player
3.8 Future market trends
3.9 Porter’s analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Indication, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Psoriasis
5.3 Rheumatoid arthritis
5.4 Cancer
5.5 Other indications
Chapter 6 Market Estimates and Forecast, By Drug Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Branded
6.3 Generic
Chapter 7 Market Estimates and Forecast, By Drug Form, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Tablet
7.3 Liquid
7.4 Injectable
Chapter 8 Market Estimates and Forecast, By Route of Administration, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Oral
8.3 Subcutaneous
8.4 Intramuscular
8.5 Intravenous
Chapter 9 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Hospital pharmacies
9.3 Retail pharmacies
9.4 Online pharmacies
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.3.7 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Accord Healthcare
11.2 Amneal Pharmaceuticals LLC
11.3 Apotex Inc.
11.4 Cipla Limited
11.5 Dr. Reddy’s Laboratories Ltd.
11.6 Hikma Pharmaceuticals PLC
11.7 Intas Pharmaceuticals Ltd.
11.8 Lupin Limited
11.9 Merck KGaA
11.10 Novartis AG
11.11 Pfizer Inc.
11.12 Sun Pharmaceutical Industries Ltd.
11.13 Teva Pharmaceutical Industries Ltd.
11.14 Viatris Inc.
11.15 Zydus Cadila
